GLOBUS MEDICAL INC - A (GMED) Stock Analyst Earnings Estimates
NYSE:GMED - New York Stock Exchange, Inc. - US3795772082 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 958.1M 21.43% | 1.023B 6.75% | 1.568B 53.35% | 2.556B 62.96% | 2.725B 6.61% | 2.913B 6.90% | 3.108B 6.69% | 3.36B 8.11% | |
| EBITDA YoY % growth | 264.8M 48.51% | 304.6M 15.03% | 346.583M 13.78% | 762.6M 120.03% | 885.22M 16.08% | 985.9M 11.37% | 1.116B 13.20% | 1.138B 1.97% | |
| EBIT YoY % growth | 194.9M 68.89% | 236.3M 21.24% | 201.85M -14.58% | 526.28M 160.73% | 628.03M 19.33% | 710.49M 13.13% | 773.87M 8.92% | N/A | |
| Operating Margin | 20.34% | 23.10% | 12.87% | 20.59% | 23.05% | 24.39% | 24.90% | N/A | |
| EPS YoY % growth | 2.04 42.66% | 2.07 1.47% | 2.33 12.56% | 3.04 30.63% | 3.48 14.42% | 3.98 14.36% | 4.59 15.24% | 4.94 7.56% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.75 25.53% | 0.80 10.67% | 0.88 16.68% | 0.86 3.81% | 0.91 20.36% | 0.98 23.23% | 1.03 17.65% | 1.02 18.46% | 1.04 15.15% |
| Revenue Q2Q % growth | 649.59M 5.36% | 656.56M 8.22% | 682.34M 8.36% | 677.13M 8.22% | 693.55M 6.77% | 702.04M 6.93% | 731.96M 7.27% | 726.5M 7.29% | 739.33M 6.60% |
| EBITDA Q2Q % growth | 208.08M 21.91% | 208.69M 146.14% | 221.12M 20.85% | 218.14M -7.09% | 229.42M 10.26% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 127.44M 391.02% | 142.25M 381.80% | 148.28M 131.24% | 141.99M 189.80% | 156.7M 22.96% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.83 45.61% | 0.66 | 0.17 | 25.45% |
| Q2 2024 Q2Q % growth | 0.75 19.05% | 0.69 | 0.06 | 8.60% |
| Q1 2024 Q2Q % growth | 0.72 35.85% | 0.58 | 0.14 | 24.38% |
| Q4 2023 Q2Q % growth | 0.60 1.69% | 0.62 | -0.02 | -3.57% |
| Q3 2023 Q2Q % growth | 0.57 14.00% | 0.58 | -0.01 | -2.25% |
| Q2 2023 Q2Q % growth | 0.63 12.50% | 0.61 | 0.02 | 4.09% |
| Q1 2023 Q2Q % growth | 0.53 26.19% | 0.52 | 0.01 | 2.20% |
| Q4 2022 Q2Q % growth | 0.59 20.41% | 0.57 | 0.02 | 3.24% |
| Q3 2022 Q2Q % growth | 0.50 | 0.53 | -0.03 | -5.77% |
| Q2 2022 Q2Q % growth | 0.56 | 0.54 | 0.02 | 2.86% |
| Q1 2022 Q2Q % growth | 0.42 -14.29% | 0.48 | -0.06 | -11.98% |
| Q4 2021 Q2Q % growth | 0.49 -15.52% | 0.48 | 0.01 | 1.69% |
| Q3 2021 Q2Q % growth | 0.50 2.04% | 0.46 | 0.04 | 8.54% |
| Q2 2021 Q2Q % growth | 0.56 700.00% | 0.45 | 0.11 | 23.57% |
| Q1 2021 Q2Q % growth | 0.49 68.97% | 0.37 | 0.12 | 30.88% |
| Q4 2020 Q2Q % growth | 0.58 18.37% | 0.52 | 0.06 | 11.85% |
| Q3 2020 Q2Q % growth | 0.49 13.95% | 0.31 | 0.18 | 58.93% |
| Q2 2020 Q2Q % growth | 0.07 -82.93% | -0.11 | 0.18 | 164.34% |
| Q1 2020 Q2Q % growth | 0.29 -19.44% | 0.39 | -0.10 | -25.75% |
| Q4 2019 Q2Q % growth | 0.49 | 0.53 | -0.04 | -8.23% |
| Q3 2019 Q2Q % growth | 0.43 | 0.43 | 0.00 | -0.16% |
| Q2 2019 Q2Q % growth | 0.41 | 0.42 | -0.01 | -1.72% |
| Q1 2019 Q2Q % growth | 0.36 | 0.42 | -0.06 | -14.59% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 625.705M 63.10% | 616.01M | 9.695M | 1.57% |
| Q2 2024 Q2Q % growth | 629.691M 115.93% | 627.65M | 2.041M | 0.33% |
| Q1 2024 Q2Q % growth | 606.666M 119.26% | 598.88M | 7.786M | 1.30% |
| Q4 2023 Q2Q % growth | 616.534M 124.60% | 620.2M | -3.666M | -0.59% |
| Q3 2023 Q2Q % growth | 383.639M 50.98% | 435.83M | -52.191M | -11.98% |
| Q2 2023 Q2Q % growth | 291.615M 10.63% | 285.32M | 6.295M | 2.21% |
| Q1 2023 Q2Q % growth | 276.688M 20.04% | 260.39M | 16.298M | 6.26% |
| Q4 2022 Q2Q % growth | 274.5M 9.80% | 282.2M | -7.7M | -2.73% |
| Q3 2022 Q2Q % growth | 254.1M 10.62% | 258.21M | -4.11M | -1.59% |
| Q2 2022 Q2Q % growth | 263.6M 5.02% | 264.58M | -980K | -0.37% |
| Q1 2022 Q2Q % growth | 230.5M 1.41% | 238.85M | -8.35M | -3.50% |
| Q4 2021 Q2Q % growth | 250M 7.11% | 248.39M | 1.61M | 0.65% |
| Q3 2021 Q2Q % growth | 229.7M 6.29% | 232.87M | -3.17M | -1.36% |
| Q2 2021 Q2Q % growth | 251M 68.57% | 229.98M | 21.02M | 9.14% |
| Q1 2021 Q2Q % growth | 227.3M 19.25% | 202.36M | 24.94M | 12.32% |
| Q4 2020 Q2Q % growth | 233.4M 10.25% | 235.84M | -2.44M | -1.03% |
| Q3 2020 Q2Q % growth | 216.1M 10.14% | 200.05M | 16.05M | 8.02% |
| Q2 2020 Q2Q % growth | 148.9M -23.44% | 101.72M | 47.18M | 46.38% |
| Q1 2020 Q2Q % growth | 190.6M 4.21% | 198.39M | -7.79M | -3.93% |
| Q4 2019 Q2Q % growth | 211.7M | 214.64M | -2.94M | -1.37% |
| Q3 2019 Q2Q % growth | 196.2M | 189.57M | 6.63M | 3.50% |
| Q2 2019 Q2Q % growth | 194.5M | 188.63M | 5.87M | 3.11% |
| Q1 2019 Q2Q % growth | 182.9M | 190.32M | -7.42M | -3.90% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.45% | 0% | 4.6% |
| Revenue | 0% | -1.78% | 0.35% | 0.99% |